0001062993-23-016040.txt : 20230808
0001062993-23-016040.hdr.sgml : 20230808
20230808173105
ACCESSION NUMBER: 0001062993-23-016040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230805
FILED AS OF DATE: 20230808
DATE AS OF CHANGE: 20230808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kummeth Charles R.
CENTRAL INDEX KEY: 0001534980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 231152697
MAIL ADDRESS:
STREET 1: 425 MARTINGALE ROAD
STREET 2: SUITE 1000
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173-2213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-05
0000842023
BIO-TECHNE Corp
TECH
0001534980
Kummeth Charles R.
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-08-05
4
M
0
51516
0
A
1310282
D
Common Stock
2023-08-05
4
F
0
31962
82.17
D
1278320
D
Common Stock
400
I
By Step-Son
Common Stock
400
I
By Step-Daughter
Stock Options (Right to Buy)
31.2625
2024-08-09
Common Stock
779084
779084
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
361336
361336
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
240888
240888
D
Stock Options (Right to Buy)
47.6025
2026-08-07
Common Stock
342900
342900
D
Stock Options (Right to Buy)
47.6025
2026-08-07
Common Stock
228600
228600
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
66600
66600
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
299768
299768
D
Restricted Stock Units
2023-08-05
4
M
0
51516
0
D
Common Stock
51516
0
D
Restricted Stock Units
Common Stock
52900
52900
D
Stock Options (Right to Buy)
66.9675
2027-08-05
Common Stock
153180
153180
D
Restricted Stock Units
Common Stock
32064
32064
D
Stock Options (Right to Buy)
120.455
2028-08-06
Common Stock
125260
125260
D
Stock Options (Right to Buy)
120.455
2028-08-06
Common Stock
83504
83504
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
600000
600000
D
Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024.
Fully exercisable.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs.
17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
/s/ Andrew Nick, as Attorney-in-Fact pursuant to Power of Attorney previously filed.
2023-08-08